Tissue Regenix Group plc (AIM:TRX)
London · Delayed Price · Currency is GBP · Price in GBX 7.25
0.00 (0.00%)
Inactive · Last trade price on Oct 22, 2025
Tissue Regenix Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 27.75 | 28.65 | 26.32 | 24.48 | 19.75 | 16.47 | |
Revenue Growth (YoY) | 4.29% | 8.85% | 7.52% | 23.95% | 19.87% | -4.57% |
Cost of Revenue | 16.38 | 15.03 | 13.34 | 13.22 | 11.27 | 8.9 |
Gross Profit | 11.37 | 13.62 | 12.98 | 11.26 | 8.48 | 7.57 |
Selling, General & Admin | 11.71 | 13.15 | 13.59 | 13.27 | 12.5 | 12.93 |
Other Operating Expenses | 0.12 | 0.12 | - | - | - | -1.06 |
Operating Expenses | 11.84 | 13.27 | 13.59 | 13.27 | 12.5 | 11.87 |
Operating Income | -0.46 | 0.35 | -0.61 | -2.01 | -4.02 | -4.3 |
Interest Expense | -1.06 | -0.92 | -1.05 | -0.83 | -0.77 | -0.57 |
Interest & Investment Income | 0.01 | 0.01 | 0.03 | 0.01 | 0 | 0 |
Other Non Operating Income (Expenses) | - | - | -0.25 | - | - | - |
EBT Excluding Unusual Items | -1.52 | -0.56 | -1.89 | -2.83 | -4.79 | -4.87 |
Merger & Restructuring Charges | - | - | - | - | - | -0.45 |
Impairment of Goodwill | - | - | - | - | - | -7.87 |
Other Unusual Items | - | - | - | - | -0.36 | 0.04 |
Pretax Income | -1.52 | -0.56 | -1.89 | -2.83 | -5.14 | -13.15 |
Income Tax Expense | -0.09 | 0.29 | -0.01 | -0.23 | -0.16 | -0.68 |
Earnings From Continuing Operations | -1.43 | -0.85 | -1.88 | -2.6 | -4.99 | -12.47 |
Earnings From Discontinued Operations | 0.02 | 0.17 | 0.22 | - | - | - |
Net Income to Company | -1.41 | -0.68 | -1.66 | -2.6 | -4.99 | -12.47 |
Minority Interest in Earnings | 0.04 | -0.03 | -0.06 | -0.1 | 0.19 | -0 |
Net Income | -1.37 | -0.71 | -1.71 | -2.7 | -4.79 | -12.47 |
Net Income to Common | -1.37 | -0.71 | -1.71 | -2.7 | -4.79 | -12.47 |
Shares Outstanding (Basic) | 71 | 71 | 70 | 70 | 70 | 44 |
Shares Outstanding (Diluted) | 71 | 71 | 70 | 70 | 70 | 44 |
Shares Change (YoY) | 1.29% | 0.80% | 0.12% | 0.02% | 58.13% | 279.54% |
EPS (Basic) | -0.02 | -0.01 | -0.02 | -0.04 | -0.07 | -0.28 |
EPS (Diluted) | -0.02 | -0.01 | -0.02 | -0.04 | -0.07 | -0.28 |
Free Cash Flow | -3.54 | -4.93 | 0.63 | -1.68 | -4.53 | -7.63 |
Free Cash Flow Per Share | -0.05 | -0.07 | 0.01 | -0.02 | -0.06 | -0.17 |
Gross Margin | 40.98% | 47.55% | 49.32% | 46.00% | 42.93% | 45.95% |
Operating Margin | -1.67% | 1.22% | -2.33% | -8.21% | -20.37% | -26.09% |
Profit Margin | -4.92% | -2.49% | -6.51% | -11.01% | -24.27% | -75.67% |
Free Cash Flow Margin | -12.77% | -17.22% | 2.38% | -6.84% | -22.92% | -46.31% |
EBITDA | 0.52 | 1.29 | 0.23 | -1.04 | -3.04 | -3.32 |
EBITDA Margin | 1.86% | 4.50% | 0.88% | -4.25% | -15.37% | -20.17% |
D&A For EBITDA | 0.98 | 0.94 | 0.85 | 0.97 | 0.99 | 0.98 |
EBIT | -0.46 | 0.35 | -0.61 | -2.01 | -4.02 | -4.3 |
EBIT Margin | -1.67% | 1.22% | -2.33% | -8.21% | -20.37% | -26.09% |